Immunotech Biopharm Ltd
Company Profile
Business description
Immunotech Biopharm Ltd is a cellular immunotherapy biopharmaceutical company in China. The company is focused on the research, development, and commercialization of T-cell immunotherapy. Its product EAL is a multi-target cellular immunotherapy product for the treatment of various types of cancer. Its product pipeline features classes of cellular immunotherapy products, including both non-genetically modified and genetically modified products, as well as both multi-target and single-target products. Its other products include the CAR-T cell series and the TCR-T cell series.
Contact
No.1 Kangding Street
8th Floor, Block 1, Guosheng Technology Park
Beijing Economic-technological Development Area
Beijing100176
CHNT: +86 1088400152
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
202
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,683.40 | 50.00 | 0.58% |
CAC 40 | 7,879.93 | 26.47 | -0.33% |
DAX 40 | 21,552.15 | 46.45 | 0.22% |
Dow JONES (US) | 44,623.59 | 67.55 | 0.15% |
FTSE 100 | 8,617.15 | 46.38 | 0.54% |
HKSE | 20,597.09 | 192.87 | -0.93% |
NASDAQ | 19,590.68 | 63.34 | -0.32% |
Nikkei 225 | 38,831.48 | 33.11 | 0.09% |
NZX 50 Index | 12,844.59 | 60.45 | -0.47% |
S&P 500 | 6,034.08 | 3.80 | -0.06% |
S&P/ASX 200 | 8,416.90 | 42.90 | 0.51% |
SSE Composite Index | 3,229.49 | 21.11 | -0.65% |